Also, rapamycin ameliorated signs of senescence in MSCs from patients with systemic lupus erythematosus (SLE) and enhanced the immunomodulatory potency of MSCs from MRL/lpr mice through inhibition of mTOR signaling pathways [112]. Here, MTOR is linked to systemic lupus erythematosus.